Compare FANG & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FANG | CAH |
|---|---|---|
| Founded | 2007 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.9B | 49.4B |
| IPO Year | 2012 | N/A |
| Metric | FANG | CAH |
|---|---|---|
| Price | $157.01 | $197.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | $186.61 | ★ $200.25 |
| AVG Volume (30 Days) | 1.6M | ★ 2.3M |
| Earning Date | 11-03-2025 | 01-29-2026 |
| Dividend Yield | ★ 2.55% | 1.03% |
| EPS Growth | N/A | ★ 27.25 |
| EPS | ★ 14.37 | 6.63 |
| Revenue | $14,626,000,000.00 | ★ $234,310,000,000.00 |
| Revenue This Year | $43.41 | $16.60 |
| Revenue Next Year | N/A | $8.92 |
| P/E Ratio | ★ $10.91 | $29.91 |
| Revenue Growth | ★ 59.73 | 4.39 |
| 52 Week Low | $114.00 | $114.60 |
| 52 Week High | $180.91 | $214.93 |
| Indicator | FANG | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 49.55 |
| Support Level | $155.67 | $197.36 |
| Resistance Level | $160.86 | $202.22 |
| Average True Range (ATR) | 4.09 | 3.39 |
| MACD | 0.20 | -2.63 |
| Stochastic Oscillator | 63.25 | 2.79 |
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.